<DOC>
	<DOC>NCT00782470</DOC>
	<brief_summary>Understanding how often the bleeding events occur in the subjects who voluntarily decide to switch from prophylaxis to on-demand and in those subjects who remain on prophylaxis. Also look into the consequences of switching treatment in QoL (quality of life), development of target joints, activity level and reasons that might influence the desire to switch.</brief_summary>
	<brief_title>Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Severe hemophilia A (&lt;2%) For subjects who elect staying on Prophylaxis only: Have been on continuous prophylactic treatment for the past 5 years prior to study entry For subjects who elect switching to ondemand only: Have been on continuous prophylactic treatment for the past 5 years, but may have been on intermediate or reduced prophylaxis for the 112 months prior to study entry For subjects currently ondemand: a retrospective arm of subjects who have been on continuous prophylactic treatment for at least 5 years and switched to ondemand treatment between 13 and 24 months prior to study entry Current treatment with rFVIII Other known hematological / bleeding disorders other than hemophilia A Participating on another study that may have an impact on bleeding or the objectives of this study Known alcohol and drug abuse</criteria>
	<gender>Male</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>